Pfizer is one of the companies that pays its shareholders a dividend every year. This dividend also tends to be relatively stable over time, which attracts many investors looking for a regular income. On this page, we'll tell you everything you need to know about Pfizer's dividend, including the exact current amount, yield, price and yield history over the last ten years, and exact ex-dividend and payout dates.
The last known full dividend for Pfizer stock is the dividend that was paid in 2021 for the financial year 2020. This dividend was in the amount of $1.56 per share and was paid in four installments of $0.39
Pfizer has also already paid two interim dividends of $0.40 per share in 2022 in respect of the 2021 financial year.
The Pfizer stock dividend is calculated and paid each year for the previous year's fiscal year after going through several steps. The first is the determination of the amount by the Board of Directors. It is then presented to shareholders for a vote at the annual general meeting.
Like most other publicly traded companies in the US, Pfizer Group has a quarterly dividend payment schedule, which means that the dividend is paid in four installments.
In 2021, for example, Pfizer's first interim dividend was detached on 28 January and paid on 5 March, the second was detached on 06 May and paid on 04 June, the third was detached on 29 July and paid on 27 September and the fourth was detached on 04 November and paid on 05 December.
Pfizer Group has already approved its dividend for the year 2022 and for the financial year 2021. Indeed, two first payments have already been made to shareholders, in the amount of $0.40 each, in March and June. Two other payments of $0.40 will be made in September and December. This represents a total annual dividend of $1.60 per share.
This new dividend is therefore higher than the one paid in 2021, which was then a total of $1.56 per share.
Historically, Pfizer has been one of the longest dividend payers in the industry. Since 1980, Pfizer has paid a dividend to its shareholders every year without interruption, for over 40 years. Here is a complete history of Pfizer's dividend payout over the last ten years and how it has evolved.
The analysis of this history clearly shows us that the amount of the dividend paid by Pfizer evolves in an upward direction over time. Indeed, over the last 5 years, the amount of this dividend has increased by an average of 4.30% per year. Over the last ten years, this increase has been on average 6.03% per year.
The Pfizer dividend yield is actually the annual amount of the dividend divided by the share price. It thus serves as a more accurate reflection of the profitability of the stock for the investors who hold it.
Pfizer's 2022 dividend yield was 3.02%.
We can also look at Pfizer's payout ratio which is currently 35.36%. This is a relatively good level and shows that the company is not dipping too much into its profits for its dividend.
Over the past 10 years, Pfizer Group has paid a dividend with an average yield of 3.53%, which is similar to its 2021 yield level. Here is its history:
eToro is a multi-asset platform which offers both investing in stocks and cryptoassets, as well as trading CFDs.
Please note that CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail CFD accounts lose money. You should consider whether you can afford to take the high risk of losing your money.
Past performance is not an indication of future results. Trading history presented is less than 5 complete years and may not suffice as basis for investment decision.
Copy trading is a portfolio management service, provided by eToro (Europe) Ltd., which is authorised and regulated by the Cyprus Securities and Exchange Commission.
Cryptoasset investing is unregulated in some EU countries and the UK. No consumer protection. Your capital is at risk.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro.